Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
In vivo binding of SCH 39166: a D-1 selective antagonistR D McQuade, R A Duffy, V L Coffin, et al.Neuroscience Letters|June 15, 1984
Behavioral interaction of adenosine and methylxanthines on central purinergic systemsV L Coffin, J A Taylor, J W Phillis, et al.The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activityR E Chipkin, L C Iorio, V L Coffin, et al.Journal of Neurochemistry|December 1, 1991
[3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analysesR D McQuade, R A Duffy, C C Anderson, et al.Psychopharmacology|January 1, 1993
Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in ratsC E Tedford, V L Coffin, V Ruperto, et al.Bioorganic & Medicinal Chemistry Letters|January 2, 2001
Benzylidene ketal derivatives as M2 muscarinic receptor antagonistsC D Boyle, S Chackalamannil, L Y Chen, et al.European Journal of Pharmacology|December 1, 2001
SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animalsG J Carey, W Billard, H Binch, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Metabolic stabilization of benzylidene ketal M(2) muscarinic receptor antagonists via halonaphthoic acid substitutionC D Boyle, S Chackalamannil, J W Clader, et al.Pageof 3